Hi Welcome You can highlight texts in any article and it becomes audio news that you can hear
  • Tue. Nov 5th, 2024

Could an antiparasitic drug exterminate SARS-CoV-2 within 2 days?

Byindianadmin

Apr 22, 2020
Could an antiparasitic drug exterminate SARS-CoV-2 within 2 days?

A new study in cell cultures recommends that ivermectin, an existing antiparasitic drug, is able to eliminate SARS-CoV-2 within 48 hours. Nevertheless, whether this approach is safe and efficient in human beings stays to be seen.

two scientists wearing protective equipment studying cells under a microscope Share on Pinterest
New research study suggests that an existing antiparasitic drug may effectively battle the new coronavirus.

As the race towards an efficient treatment for coronavirus illness 19 (COVID-19) continues, researchers are explore new and old drugs alike.

A study paper recently published in the journal Antiviral Research suggests that private investigators from the Victorian Infectious Diseases Reference Lab (VIDRL) and Monash University, both in Melbourne, Australia, may have found a feasible treatment: an existing antiparasitic drug called ivermectin.

Ivermectin treats parasitic invasions such as those triggered by head lice and scabies. Past research has suggested that it may likewise have the ability to fight off some infections, consisting of HIV-1 and dengue infection.

Stay notified with live updates on the existing COVID-19 outbreak and visit our coronavirus hub for more recommendations on prevention and treatment.

The researchers behind today study have actually now revealed, through laboratory experiments in cell cultures, that the drug might combat serious acute breathing syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19

The investigators infected cell cultures with SARS-CoV-2 isolates, then treated them with 5 micromoles of ivermectin.

” We found that even a single dosage could basically eliminate all viral RNA by 48 hours which even at 24 hours, there was a really substantial reduction in it,” states lead scientist Kylie Wagstaff, Ph.D.

While t

Find Out More

Click to listen highlighted text!